[PDF][PDF] The evidence base on the impact of price controls on medical innovation
T Philipson, T Durie - Becker Friedman Institute of Economics …, 2021 - papers.ssrn.com
This issue brief reviews the evidence on the impact of price controls on biopharmaceutical
innovation and calibrates what this evidence implies for recent price control proposals in the …
innovation and calibrates what this evidence implies for recent price control proposals in the …
A new model for pricing drugs of uncertain efficacy
DP Goldman, K Van Nuys, WH Cheng, JP Hlávka… - NEJM …, 2018 - catalyst.nejm.org
Are we paying too much for new drugs before we know how well they work? This innovative
pricing model proposes postponing major rewards until efficacy is established—which could …
pricing model proposes postponing major rewards until efficacy is established—which could …
Development of a group judgment process for forecasts of health care innovations
PG Shekelle, DP Goldman - JAMA Network Open, 2018 - jamanetwork.com
Importance Health care costs have increased substantially over the past few decades, in
part owing to the development and diffusion of new medical treatments. Forecasting …
part owing to the development and diffusion of new medical treatments. Forecasting …
[PDF][PDF] Issue Brief: The Evidence Base on The Impact of Price Controls on Medical Innovation
TJ Philipson, T Durie - 2021 - ecchc.economics.uchicago.edu
This issue brief reviews the evidence on the impact of price controls on biopharmaceutical
innovation and calibrates what this evidence implies for recent price control proposals in the …
innovation and calibrates what this evidence implies for recent price control proposals in the …